[ 6 ] Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J, 1999, 138 (5 Suppl): S419-S420.
[4]
[ 7 ] Zhao B, Stavchansky SA, Bowden RA, et al. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells[J]. Am J Physiol Cell Physiol, 2003, 284(6): C1577-C1583.
[5]
[ 8 ] Satterthwaite G, Francis SE, Suvarna K, et al. Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis[J]. Am Heart J, 2005, 150(3): 488-499.
[6]
[ 9 ] Kiechl S，Willeit J. The nature course of atherosclerosis partⅡ：vascular remodeling[J]. Arterioscler Thromb Vasc Biol, l999, 19(5): l49l-1498.
[7]
Shiffman D, Mikita T, Tai JT, et al. Large scale gene expression analysis of cholesterol-loaded macrophages[J]. J Biol Chem, 2000, 275(48): 37324-37332.
[8]
[ 1 ] Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque[J]. Arterioscler Thromb Vasc Biol, 2010, 30(7): 1282-1292.
[9]
[ 2 ] Fishbein MC. The vulnerable and unstable atherosclerotic plaque[J]. Cardiovasc Pathol, 2010, 19(1): 6-11.
[10]
[ 3 ] Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology[J]. Trends Biotechnol, 2006, 24(4): 150-154.
Li H, Lewis A, Brodsky S, et al. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis[J]. Circulation, 2002, 105(9): 1037-1043.
[14]
Katsuda S, Kaji T. Atherosclerosis and extracellular matrix[J]. J Atheroscler Thromb, 2003, 10(5): 267-274.
[15]
Vivanco F, Martín-Ventura JL, Duran MC, et al. Quest for novel cardiovascular biomarkers by proteomic analysis[J]. J Proteome Res, 2005, 4(4): 1181-1191.
[16]
Bengtsson E, To F, Grubb A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J]. Atherosclerosis, 2005, 180(1): 45-53.
